M35.7
Hypermobility syndrome
Clinical Classification Guidelines
Inclusion Terms
- Familial ligamentous laxity
Excludes Type 1
- ligamentous laxity, NOS (M24.2-)
Excludes Type 2
- Ehlers-Danlos syndromes (Q79.6-)
Medical Intelligence & Overview
Hypermobility syndrome, also known as joint hypermobility syndrome, is a condition characterized by joints that move beyond their normal range of motion. Often linked to familial patterns of ligamentous laxity, this condition can cause joint pain, instability, and other related symptoms. While some individuals experience minimal issues, others may face significant mobility challenges, making understanding this syndrome essential for effective management and care.
Causes & Symptoms
Clinical Causes: Genetic factors leading to familial ligamentous laxity Inherited connective tissue disorders, such as Ehlers-Danlos syndrome or Marfan syndrome Structural abnormalities in collagen or other connective tissue proteins Family history of joint hypermobility or related connective tissue conditions Potential environmental influences during developmental stages
Key Symptoms: Excessive flexibility in joints, often beyond normal limits Joint pain and tenderness, especially after physical activity Frequent joint dislocations or subluxations Joint instability or feeling of 'looseness' in certain areas Muscle fatigue or weakness due to compensatory movements Skin that is sometimes soft, stretchy, or unusually elastic Potential for scoliosis or other skeletal deformities In some cases, associated symptoms like fatigue, dizziness, or chronic pain
Diagnostic & Treatment
Diagnosis Path: Diagnosis is primarily clinical, based on patient history and physical examination. Healthcare providers look for signs of joint hypermobility, familial patterns, and other systemic features. Specific tools such as the Beighton score may be used to assess joint flexibility. In some cases, additional imaging or laboratory tests are performed to rule out related connective tissue diseases. Early diagnosis helps in managing symptoms and preventing complications.
Treatment Protocols: There is no cure for hypermobility syndrome, but various strategies can help manage its symptoms. These include:
Clinical Advice & FAQs
Billing Guidance
Is M35.7 a billable ICD-10 code?
Yes, M35.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M35.7?
Clinical documentation must specify the nature of Hypermobility syndrome and any associated comorbidities for accurate reporting.
Cite this Clinical Reference